Results 121 to 130 of about 31,441 (254)

State-of-the-Art of Transcatheter Left Atrial Appendage Occlusion

Journal of Clinical Medicine
Left atrial appendage occlusion (LAAO) is an increasingly used alternative to oral anticoagulation in patients with atrial fibrillation, especially in patients with absolute/relative contraindications to these therapies. This review will cover three main
L. Pastormerlo, A. D. De Caterina, Augusto Esposito, K. Korsholm, S. Berti   +4 more
semanticscholar   +1 more source

In-hospital safety outcomes of left atrial appendage occlusion in octogenarians and nonagenarians

Europace
Aims Data on safety outcomes of left atrial appendage occlusion (LAAO) in elderly patients are limited. This study aimed to compare the outcomes of LAAO between octogenarians (age 80–89) and nonagenarians (age ≥90) vs. younger patients (age ≤79). Methods
M. Ismayl, Hasaan Ahmed, A. Goldsweig, James V. Freeman, M. Alkhouli   +4 more
semanticscholar   +1 more source

Patients with Gastrointestinal Bleeding and Atrial Fibrillation: Potential Ideal Target for Epicardial Appendage Occlusion

Journal of Cardiovascular Development and Disease
Background: Gastrointestinal bleeding in patients with atrial fibrillation is an indication for left appendage occlusion. All endovascular devices mandate antithrombotic therapies: rebleeding risk remains an issue.
Stefano Branzoli, Massimiliano Marini, Domenico Catanzariti, Cecilia Pravadelli, Luigi Pannone, Giovanni D’Onghia, Mauro Fantinel, Fabrizio Guarracini, Gaia Franceschini, Mirco Zadro, Giulia Baroni, Silvia Casagrande, Donatella Ottaviani, Renato Turco, Serena Nicolussi Paolaz, Luciano Annicchiarico, Francesco Corsini, Roberto Rordorf, Kausilia Krishnadath, Flavia Ravelli, Carlo de Asmundis, Mark La Meir   +21 more
doaj   +1 more source

Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device

Vascular Health and Risk Management, 2017
Arash Alipour, Lisette I S Wintgens, Martin J Swaans, Jippe C Balt, Benno J W M Rensing, Lucas V A Boersma Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands Abstract: Atrial fibrillation (AF) remains an
Alipour A, Wintgens LIS, Swaans MJ, Balt JC, Rensing BJWM, Boersma LVA   +5 more
doaj  

Retrospective study on the efficacy of one-stop synchronous versus asynchronous ablation for atrial fibrillation

Zhongguo linchuang yanjiu
Objective To compare the efficacy of synchronous versus asynchronous catheter ablation (CA) combined with left atrial appendage occlusion (LAAO) in patients with atrial fibrillation.
KONG Xiangmeng, ZHANG Qingyong
doaj   +1 more source

Left atrial appendage occlusion EP course

Heart Vessels and Transplantation, 2022
Luis A. Arabia
doaj   +1 more source

Percutaneous Left Atrial Appendage Occlusion: A View From the UK

Arrhythmia & Electrophysiology Review, 2020
Wern Yew Ding, Dhiraj Gupta
doaj   +1 more source

Left atrial appendage occlusion in patients suffering from advanced chronic kidney disease (stage 4 and 5). Long‐term follow‐up

Catheterization and cardiovascular interventions
Advanced chronic kidney disease (A‐CKD) combined with atrial fibrillation increases the risk of both thrombogenic and bleeding events. Left atrial appendage occlusion (LAAO) may be an alternative to oral anticoagulation to prevent thromboembolic events ...
S. López-Tejero, Pablo J Antúnez-Muiños, Pilar Fraile-Gómez, Gilles Barreira‐de Sousa, Javier Rodríguez‐Collado, J. Herrero-Garibi, Fabián Blanco-Fernández, Alejandro Diego-Nieto, Gonzalo C. Delgado‐Lapeira, M. Candelas Pérez Villar‐Moro, Javier Martín-Moreiras, P. L. Sánchez‐Fernández, Ignacio Cruz-González   +12 more
semanticscholar   +1 more source

Advances in emerging therapies 2009 [PDF]

, 2010
Lees, K.R., McArthur, K.
core   +1 more source

Left atrial appendage occlusion: Percutaneous and surgical approaches in everyday practice.

Kardiologia polska
Prophylactic left atrial appendage occlusion has been suggested as a means of cardioembolism risk reduction in patients with atrial fibrillation. Its clinical benefits have been discussed together with potential endocrine or hemodynamic adverse effects ...
Jan Gofus, Pavel Zacek, Youssef Shahin, K. Mědílek, L. Haman, Jan Vojacek   +5 more
semanticscholar   +1 more source